Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CEO Jitendra Mohan sold 94,971 shares of the stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at approximately $179,863,615.59. The trade was a 6.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Astera Labs Stock Performance
ALAB stock traded down $0.96 during mid-day trading on Friday, hitting $131.66. The company had a trading volume of 757,372 shares, compared to its average volume of 5,598,292. The firm has a market cap of $22.24 billion, a PE ratio of 108.01, a price-to-earnings-growth ratio of 2.55 and a beta of 1.50. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock’s fifty day moving average price is $160.78 and its two-hundred day moving average price is $174.12.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same period in the prior year, the firm earned $0.37 EPS. The company’s revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.
Institutional Trading of Astera Labs
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on ALAB shares. Stifel Nicolaus upped their price target on Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Raymond James Financial initiated coverage on shares of Astera Labs in a research report on Friday, November 21st. They set a “hold” rating for the company. Needham & Company LLC lifted their target price on shares of Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research note on Wednesday, November 5th. Roth Mkm upped their price target on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Fourteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $192.89.
Check Out Our Latest Stock Analysis on Astera Labs
Trending Headlines about Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Analyst note: Zacks highlights rising AI connectivity demand and Astera’s expansion of its NVLink and Scorpio product lines, framing a multiyear market opportunity that management is targeting (potential upside to revenue growth). ALAB Rides on Strong Connectivity Demand
- Positive Sentiment: Fundamentals & liquidity: A Seeking Alpha piece notes revenue more than doubled YoY, very strong free cash flow margins (above 30%), and a cash position of roughly $1.19B with zero debt — giving Astera financial flexibility to invest or weather headwinds. The Great Astera Labs Reset
- Neutral Sentiment: Short-interest data is effectively immaterial/odd (reported as zero shares and a 0.0 days ratio), so there’s no clear short-pressure signal to explain intraday moves. This looks like a non-factor for current trading dynamics. Short Interest Report
- Negative Sentiment: CEO sale: CEO Jitendra Mohan sold 94,971 shares at ~$123.81 (≈$11.76M), trimming his holding by ~6.14% — a large, pre-scheduled or open-market sale that can be viewed negatively by the market when combined with other insider activity. CEO Form 4
- Negative Sentiment: COO sale: COO Sanjay Gajendra sold 94,971 shares at ~$123.81 (≈$11.76M), reducing his position by ~5.84% — another large insider disposition on the same date that amplifies investor concern. COO Form 4
- Negative Sentiment: CFO sale: CFO Michael Truett Tate sold 12,001 shares at ~$123.81 (≈$1.49M), cutting his stake by ~5.88% — another senior officer sale the same day. CFO Form 4
- Negative Sentiment: General Counsel sale: GC Philip Mazzara sold 4,849 shares at ~$123.80 (≈$600k), a smaller but concurrent insider reduction. Multiple senior officers selling on the same day increases perceived signal of near‑term liquidity taking or diversification by insiders. GC Form 4
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Recommended Stories
- Five stocks we like better than Astera Labs
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- From Quiet Compounder to 2026 Breakout? BSEM
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
